Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ning, Li
NCT05913037: FCN-159 in Adult Patients with Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas	Active, not recruiting	3	167	RoW	Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group (Group B): Placebo, orally, once daily;	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Neurofibromatosis 1, Plexiform Neurofibroma, NF1	08/25	06/26
NCT04381910: Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer	Completed	2	66	RoW	LY01610( Irinotecan hydrochloride liposome injection )	Luye Pharma Group Ltd.	Small Cell Lung Cancer	03/23	03/23
NCT06183736: CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency	Not yet recruiting	2	98	RoW	CVL237 tablets	Convalife (Shanghai) Co., Ltd.	Advanced Solid Tumors	06/25	06/27
NCT05380986: Camrelizumab Combined With Apatinib Mesylate	Recruiting	N/A	500	RoW	Camrelizumab combined with apatinib mesylate	Henan Cancer Hospital	Solid Tumor	05/24	05/25
Zhang, Chen
PRONE-COVID, NCT04589936: Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care	Recruiting	N/A	56	Europe	Prone positioning, Proning	Cambridge University Hospitals NHS Foundation Trust	Pneumonia, Covid19	06/21	06/21
NCT06477484: Blood Biomarkers for Screening of Alzheimer's Disease	Recruiting	N/A	180	RoW	Blood biomarker	Peking University First Hospital	Alzheimer's Disease, Blood Biomarkers	03/26	03/26
MET-LVH, NCT05719337: Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults	Recruiting	N/A	660	RoW	Echocardiography	First Hospital of China Medical University, Wuhan Union Hospital, China	Left Ventricular Hypertrophy	08/24	08/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ning, Li
NCT05913037: FCN-159 in Adult Patients with Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas	Active, not recruiting	3	167	RoW	Test group (Group A): FCN-159 8 mg, orally, once daily;, Control group (Group B): Placebo, orally, once daily;	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Neurofibromatosis 1, Plexiform Neurofibroma, NF1	08/25	06/26
NCT04381910: Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer	Completed	2	66	RoW	LY01610( Irinotecan hydrochloride liposome injection )	Luye Pharma Group Ltd.	Small Cell Lung Cancer	03/23	03/23
NCT06183736: CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency	Not yet recruiting	2	98	RoW	CVL237 tablets	Convalife (Shanghai) Co., Ltd.	Advanced Solid Tumors	06/25	06/27
NCT05380986: Camrelizumab Combined With Apatinib Mesylate	Recruiting	N/A	500	RoW	Camrelizumab combined with apatinib mesylate	Henan Cancer Hospital	Solid Tumor	05/24	05/25
Zhang, Chen
PRONE-COVID, NCT04589936: Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care	Recruiting	N/A	56	Europe	Prone positioning, Proning	Cambridge University Hospitals NHS Foundation Trust	Pneumonia, Covid19	06/21	06/21
NCT06477484: Blood Biomarkers for Screening of Alzheimer's Disease	Recruiting	N/A	180	RoW	Blood biomarker	Peking University First Hospital	Alzheimer's Disease, Blood Biomarkers	03/26	03/26
MET-LVH, NCT05719337: Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy Adults	Recruiting	N/A	660	RoW	Echocardiography	First Hospital of China Medical University, Wuhan Union Hospital, China	Left Ventricular Hypertrophy	08/24	08/25